168 related articles for article (PubMed ID: 35795985)
21. Long noncoding RNA KTN1 antisense RNA 1exerts an oncogenic function in lung adenocarcinoma by regulating DEP domain containing 1 expression via activating epithelial-mesenchymal transition.
Li YY; Li W; Chang GZ; Li YM
Anticancer Drugs; 2021 Jun; 32(6):614-625. PubMed ID: 33491970
[TBL] [Abstract][Full Text] [Related]
22. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
[TBL] [Abstract][Full Text] [Related]
23. miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a.
Cao MQ; You AB; Zhu XD; Zhang W; Zhang YY; Zhang SZ; Zhang KW; Cai H; Shi WK; Li XL; Li KS; Gao DM; Ma DN; Ye BG; Wang CH; Qin CD; Sun HC; Zhang T; Tang ZY
J Hematol Oncol; 2018 Jan; 11(1):12. PubMed ID: 29361949
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of long non‑coding RNA CCAT2 suppresses the progression of thyroid cancer by inhibiting the Wnt/β‑catenin pathway.
Xin S; Ye X
Int J Mol Med; 2020 Dec; 46(6):2047-2056. PubMed ID: 33125134
[TBL] [Abstract][Full Text] [Related]
25. Nasopharyngeal carcinoma‑associated gene 6 inhibits cell viability, migration, invasion and induces apoptosis in osteosarcoma cells by inactivating the Wnt/β‑catenin signaling pathway.
Liu L; Wang R; Zhang Z; Wang X
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300077
[TBL] [Abstract][Full Text] [Related]
26. Long non‑coding RNA NNT‑AS1 knockdown represses the progression of gastric cancer via modulating the miR‑142‑5p/SOX4/Wnt/β‑catenin signaling pathway.
Zhang J; Zhang K; Hou Y
Mol Med Rep; 2020 Aug; 22(2):687-696. PubMed ID: 32468065
[TBL] [Abstract][Full Text] [Related]
27. Linc00261 inhibits metastasis and the WNT signaling pathway of pancreatic cancer by regulating a miR‑552‑5p/FOXO3 axis.
Chen T; Lei S; Zeng Z; Zhang J; Xue Y; Sun Y; Lan J; Xu S; Mao D; Guo B
Oncol Rep; 2020 Mar; 43(3):930-942. PubMed ID: 32020223
[TBL] [Abstract][Full Text] [Related]
28. Potential role of FoxO3a in the regulation of trophoblast development and pregnancy complications.
Chen H; Tang X; Han TL; Zhu JN; Zhou W; Baker PN; Chen C; Zhang H
J Cell Mol Med; 2021 May; 25(9):4363-4372. PubMed ID: 33811439
[TBL] [Abstract][Full Text] [Related]
29. DEPDC1 upregulation promotes cell proliferation and predicts poor prognosis in patients with gastric cancer.
Gong Z; Chu H; Chen J; Jiang L; Gong B; Zhu P; Zhang C; Wang Z; Zhang W; Wang J; Li C; Zhao H
Cancer Biomark; 2021; 30(3):299-307. PubMed ID: 33361586
[TBL] [Abstract][Full Text] [Related]
30. Chromodomain Helicase DNA Binding Protein 1-like, a negative regulator of Forkhead box O3a, promotes the proliferation and migration of Angiotensin II-induced vascular smooth muscle cells.
Zhang X; Sun Y
Bioengineered; 2022 Feb; 13(2):2597-2609. PubMed ID: 35001835
[TBL] [Abstract][Full Text] [Related]
31. IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression.
Xue D; Yang P; Wei Q; Li X; Lin L; Lin T
Int J Mol Med; 2019 Nov; 44(5):1697-1706. PubMed ID: 31573051
[TBL] [Abstract][Full Text] [Related]
32. FOXO3a knockdown promotes radioresistance in nasopharyngeal carcinoma by inducing epithelial-mesenchymal transition and the Wnt/β-catenin signaling pathway.
Luo M; Wu C; Guo E; Peng S; Zhang L; Sun W; Liu D; Hu G; Hu G
Cancer Lett; 2019 Jul; 455():26-35. PubMed ID: 31022422
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis and validation reveal DEPDC1 as a potential diagnostic biomarker associated with tumor immunity in non-small-cell lung cancer.
Lv M; Li X; Yin Z; Yang H; Zhou B
PLoS One; 2024; 19(4):e0294227. PubMed ID: 38564630
[TBL] [Abstract][Full Text] [Related]
34. SP1 upregulated FoxO3a promotes tumor progression in colorectal cancer.
Yu Y; Peng K; Li H; Zhuang R; Wang Y; Li W; Yu S; Liang L; Xu X; Liu T
Oncol Rep; 2018 May; 39(5):2235-2242. PubMed ID: 29565456
[TBL] [Abstract][Full Text] [Related]
35. DEPDC1 as a crucial factor in the progression of human osteosarcoma.
Shen L; Li H; Liu R; Zhou C; Bretches M; Gong X; Lu L; Zhang Y; Zhao K; Ning B; Yang SY; Zhang A
Cancer Med; 2023 Mar; 12(5):5798-5808. PubMed ID: 36479633
[TBL] [Abstract][Full Text] [Related]
36. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis.
Qian F; Hu Q; Tian Y; Wu J; Li D; Tao M; Qin L; Shen B; Xie Y
Int J Biol Sci; 2019; 15(2):369-385. PubMed ID: 30745827
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of DEPDC1 at Ser110 is required to maintain centrosome organization during mitosis.
Chen D; Ito S; Hyodo T; Asano-Inami E; Yuan H; Senga T
Exp Cell Res; 2017 Sep; 358(2):101-110. PubMed ID: 28602627
[TBL] [Abstract][Full Text] [Related]
38. FoxO3a depletion accelerates cutaneous wound healing by regulating epithelial‑mesenchymal transition through β‑catenin activation.
Liu T; Huang JZ; Lei ZY; Yan RS; Fan DL
Mol Med Rep; 2020 Mar; 21(3):1224-1232. PubMed ID: 31922245
[TBL] [Abstract][Full Text] [Related]
39. FGD5‑AS1 is an oncogenic lncRNA in pancreatic cancer and regulates the Wnt/β‑catenin signaling pathway via miR‑577.
Zhang WT; Zhang JJ; Shao Q; Wang YK; Jia JP; Qian B; Tian XW; Yan WJ
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34821374
[TBL] [Abstract][Full Text] [Related]
40. Expression of TCF3 in Wilms' tumor and its regulatory role in kidney tumor cell viability, migration and apoptosis
Zhou N; Yan B; Ma J; Jiang H; Li L; Tang H; Ji F; Yao Z
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
